Tamar Auerbach-Nevo

Company: Emendo Biotherapeutics

Job title: Vice President of Development

Bio:

VP of Development at Emendo Bio with over 15 years of experience in multiple and diverse biotech companies. Leading the development of EMD-101 for indicated for SCN from R&D to clinic.

Seminars:

Panel Discussion: Developing Scalable & Cost-Effective Manufacturing Processes 12:00 pm

Ensuring cGMP is met when progressing into the clinic Weighing up whether to develop in-house manufacturing capabilities or outsource Practical advice for overcoming inhibitive costs associated with scaling up manufacturingRead more

day: Day 1 Track B AM

The Path of EMD-101: From R&D to IND 11:30 am

Delving into the key hurdles in establishing proof of safety and efficacy ahead of an IND application Understanding the nuances of the IND application itself, and where the potential regulatory objections may arise Exploring the required CMC information needed by regulatory bodiesRead more

day: Day 1 Track B AM